A. Groffik

1.1k total citations
9 papers, 631 citations indexed

About

A. Groffik is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, A. Groffik has authored 9 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in A. Groffik's work include Urticaria and Related Conditions (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). A. Groffik is often cited by papers focused on Urticaria and Related Conditions (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Autoimmune Bullous Skin Diseases (4 papers). A. Groffik collaborates with scholars based in Germany, Spain and United States. A. Groffik's co-authors include Petra Staubach, Marcus Maurer, Karsten Weller, Martin Metz, Peter Martus, Karoline Krause, Markus Magerl, Tomasz Hawro, Thomas B. Casale and Martin K. Church and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Der Hautarzt.

In The Last Decade

A. Groffik

8 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Groffik Germany 5 534 408 343 136 122 9 631
Adriane Peveling‐Oberhag Germany 7 256 0.5× 166 0.4× 136 0.4× 83 0.6× 124 1.0× 15 372
Beatrix Irinyi Hungary 8 143 0.3× 73 0.2× 79 0.2× 170 1.3× 165 1.4× 13 346
Daniel Soteres United States 9 81 0.2× 168 0.4× 54 0.2× 14 0.1× 51 0.4× 37 270
Saki Fukaya Japan 9 72 0.1× 44 0.1× 63 0.2× 160 1.2× 74 0.6× 31 277
Kathy Taghipour United Kingdom 8 249 0.5× 272 0.7× 306 0.9× 30 0.2× 9 0.1× 11 358
Beáta Visy Hungary 10 235 0.4× 563 1.4× 209 0.6× 6 0.0× 100 0.8× 22 604
György Temesszentandrási Hungary 8 132 0.2× 325 0.8× 91 0.3× 4 0.0× 76 0.6× 11 375
Lars Steinmüller‐Magin Germany 6 113 0.2× 288 0.7× 127 0.4× 41 0.3× 71 0.6× 7 352
Pascal Guntern Switzerland 3 83 0.2× 21 0.1× 20 0.1× 21 0.2× 113 0.9× 5 222
Sota Kikuchi Japan 8 27 0.1× 15 0.0× 21 0.1× 87 0.6× 128 1.0× 12 227

Countries citing papers authored by A. Groffik

Since Specialization
Citations

This map shows the geographic impact of A. Groffik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Groffik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Groffik more than expected).

Fields of papers citing papers by A. Groffik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Groffik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Groffik. The network helps show where A. Groffik may publish in the future.

Co-authorship network of co-authors of A. Groffik

This figure shows the co-authorship network connecting the top 25 collaborators of A. Groffik. A scholar is included among the top collaborators of A. Groffik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Groffik. A. Groffik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Weller, Karsten, Ana M. Giménez‐Arnau, Jens Malte Baron, et al.. (2023). Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial. Allergy. 79(1). 93–103. 2 indexed citations
2.
Weller, Karsten, A. Groffik, Martin K. Church, et al.. (2014). Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control. Journal of Allergy and Clinical Immunology. 133(5). 1365–1372.e6. 265 indexed citations
3.
Staubach, Petra & A. Groffik. (2013). Nützliche Instrumente für die Dokumentation bei Urtikaria. Der Hautarzt. 64(9). 650–655. 6 indexed citations
4.
Weller, Karsten, A. Groffik, Markus Magerl, et al.. (2013). Development, validation, and initial results of the Angioedema Activity Score. Allergy. 68(9). 1185–1192. 125 indexed citations
5.
Groffik, A., et al.. (2012). Medikamentöse Therapie des malignen Melanoms. Der Hautarzt. 63(11). 885–898. 4 indexed citations
6.
Weller, Karsten, A. Groffik, Markus Magerl, et al.. (2012). Development and construct validation of the angioedema quality of life questionnaire. Allergy. 67(10). 1289–1298. 176 indexed citations
7.
Groffik, A., et al.. (2010). Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy. 66(2). 303–305. 51 indexed citations
8.
Hoff, Norman‐Philipp, et al.. (2008). Kutane Larva migrans. Der Hautarzt. 59(8). 622–626.
9.
Hoff, Norman‐Philipp, A. Groffik, Rosa Maria Salani Mota, et al.. (2008). Erfolgreicher Einsatz einer allogenen Stammzelltransplantation bei therapierefraktärer Mycosis fungoides. Der Hautarzt. 59(10). 779–782. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026